There were 2,012 press releases posted in the last 24 hours and 440,820 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure and Mortality in Phase 2 Clinical Trial in Patients Hospitalized with COVID-19 ARDS

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image